Single award · contract
SARS-COV-2 Therapeutic AZD7442
Award ID: W911QY20C0119
FY2020 · complete year · data as of 2026-07-12
A single federal award, with both ends of the trail linked.
$1.1B
Total award value
Award W911QY20C0119 is a contract from the Department of Defense to Astrazeneca Pharmaceuticals LP, $1.1B obligated, FY2020 to FY2023, for SARS-COV-2 Therapeutic AZD7442. It is classified as NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6550 (IN Vitro Diagnostic Substances, Reagents, Test Kits and Sets). Source
Award details
Award typeContract
PIIDW911QY20C0119
Action date2020
Period33 mo
Awarding agencyDepartment of Defense →
RecipientAstrazeneca Pharmaceuticals LP →
Place of performance—
CategoryNAICS 325412PSC 6550
Competed?Not recordedSource
Total (exact)$1,107,934,203
More awards to Astrazeneca Pharmaceuticals LP
More from Department of Defense
awarded 2016$51.3B
awarded 2017$35.7B
awarded 2017$35.1B
awarded 2001$34.2B
awarded 2011$32B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.